Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06218628
Title Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.